Clinical trial
Effect of Testosterone Therapy in Men With Alzheimer's Disease and Low…
NCT00392912 · Michael E. DeBakey VA Medical Center, U.S. Fed · Completed
Key facts
| NCT number | NCT00392912 |
|---|---|
| Title | Effect of Testosterone Therapy in Men With Alzheimer's Disease and Low Testosterone |
| Official title | A Pilot Study of the Effect of Testosterone on Cerebral Glucose Metabolism in Hypogonadal Males With Alzheimer's Disease |
| Lead sponsor | Michael E. DeBakey VA Medical Center, U.S. Fed |
| Collaborators | Solvay Pharmaceuticals Industry |
| Status | Completed |
| Study type | Interventional |
| Conditions | Alzheimer's Disease, Hypogonadism |
| Intervention type | Drug |
| Interventions | AndroGel (Solvay Pharmaceuticals) |
| Enrollment | 10 |
| Start date | Apr 1, 2007 |
| Primary completion | Nov 1, 2009 |
| Completion | Jul 1, 2010 |
| First posted | Oct 26, 2006 |
| Last update posted | Aug 19, 2010 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: